Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease
- 1 July 1991
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 14 (4) , 431-435
- https://doi.org/10.1007/bf01797916
Abstract
Enzymes involved with the metabolic transformation of xenobiotics have recently been studied in patients with the neurodegenerative diseases, Alzheimer's disease, Parkinson's disease and motor neurone disease. Defects were detected in sulphur pathways and also, in the case of Parkinson's disease, in monoamine oxidase B. The possibility exists that the ability to cope safely with endogenous and exogenous substances which have neurotoxic properties is important in the pathogenesis of these diseases. Potentially such individuals could be identified preclinically and these diseases postponed by reduction in the load of toxin or modification of the relevant enzymic activity.Keywords
This publication has 14 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Pesticide toxicity and motor neuron disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Monoamine oxidase B and Parkinson's diseaseThe Lancet, 1990
- Metabolism of low-dose paracetamol in patients with chronic neurological diseaseXenobiotica, 1990
- Platelet monoamine oxidase-B activity in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- S-METHYLATION IN MOTORNEURON DISEASE AND PARKINSON'S DISEASEThe Lancet, 1989
- Xenobiotic metabolism in Parkinson's diseaseNeurology, 1989
- Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP): Differential effects on depletion of heart norepinephrine and of striatal dopamine in miceBiochemical Pharmacology, 1987
- PRODUCTION IN NATURE OF COMPOUND RESEMBLING METHYLPHENYLTETRAHYDROPYRIDINE, A POSSIBLE CAUSE OF PARKINSON'S DISEASEThe Lancet, 1985
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979